RECRUITING

Genetics of Appendix Cancer Study

Talk to us

Conditions

Appendix CancerAppendiceal CancerAppendiceal NeoplasmsAppendiceal Mucinous NeoplasmAppendiceal AdenocarcinomaAppendiceal Carcinoid TumorAppendiceal Neoplasm Malignant SecondaryAppendix AdenocarcinomaAppendix Mucinous NeoplasmAppendix TumorAppendix Cancer MetastaticAppendix NETLow-Grade Appendix Mucinous NeoplasmHigh Grade Appendix Mucinous NeoplasmHigh Grade Appendix Mucinous AdenocarcinomaGenetics

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Official Title

Genetics of Appendix Cancer: The GAP Study

Quick Facts

Study Start:2022-11-11
Study Completion:2034-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05734430

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Known diagnosis of appendix cancer in the United States
  2. * Mentally and physically able to consent and participate in the study
  3. * Known diagnosis of appendix cancer
  4. * Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study
  5. * Mentally and physically able to consent and participate in the study
  6. * Biological parents (mother and/or father) of individuals actively participating in the GAP Study
  7. * Residing in the United States
  8. * Mentally and physically able to consent and participate in the study
  1. * Women pregnant at the time of consent
  2. * Prisoners
  3. * Unable to provide informed consent
  4. * Unable to read, write, or complete questionnaires in English

Contacts and Locations

Study Contact

GAP Study Coordinator (Rebecca B.)
CONTACT
615-936-8544
gapcancerstudy@vumc.org

Principal Investigator

Andreana N Holowatyj, PhD, MSCI
PRINCIPAL_INVESTIGATOR
Vanderbilt-Ingram Cancer Center

Study Locations (Sites)

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232
United States

Collaborators and Investigators

Sponsor: Andreana Holowatyj, PhD, MSCI

  • Andreana N Holowatyj, PhD, MSCI, PRINCIPAL_INVESTIGATOR, Vanderbilt-Ingram Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-11
Study Completion Date2034-11

Study Record Updates

Study Start Date2022-11-11
Study Completion Date2034-11

Terms related to this study

Keywords Provided by Researchers

  • Genetics

Additional Relevant MeSH Terms

  • Appendix Cancer
  • Appendiceal Cancer
  • Appendiceal Neoplasms
  • Appendiceal Mucinous Neoplasm
  • Appendiceal Adenocarcinoma
  • Appendiceal Carcinoid Tumor
  • Appendiceal Neoplasm Malignant Secondary
  • Appendix Adenocarcinoma
  • Appendix Mucinous Neoplasm
  • Appendix Tumor
  • Appendix Cancer Metastatic
  • Appendix NET
  • Low-Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Neoplasm
  • High Grade Appendix Mucinous Adenocarcinoma